BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27633398)

  • 1. WP1066 exhibits antitumor efficacy in nasal‑type natural killer/T-cell lymphoma cells through downregulation of the STAT3 signaling pathway.
    Geng L; Li X; Zhou X; Fang X; Yuan D; Wang X
    Oncol Rep; 2016 Nov; 36(5):2868-2874. PubMed ID: 27633398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
    Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
    Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
    Geng L; Lu K; Li P; Li X; Zhou X; Li Y; Wang X
    Oncotarget; 2017 Jul; 8(30):48701-48710. PubMed ID: 27275540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
    Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
    Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
    Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
    Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.
    Liu J; Liang L; Li D; Nong L; Zheng Y; Huang S; Zhang B; Li T
    Oncol Rep; 2019 Jun; 41(6):3219-3232. PubMed ID: 31002364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma.
    Liu S; Li C; Xin P; Zheng Y; Peng Q; Xu Y; Luo Y; Wu Y; Zhu X
    Med Sci Monit; 2019 Nov; 25():8579-8586. PubMed ID: 31724562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
    Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice.
    Yu J; Yuan X; Liu Y; Zhang K; Wang J; Zhang H; Liu F
    Lung; 2016 Feb; 194(1):67-74. PubMed ID: 26563331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
    Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
    Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
    Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell adhesion molecules and chemokine receptors: angioinvasiveness in nasal NK/T-cell lymphoma.
    Liu A; Nakatsuka S; Yang WI; Kojya S; Aozasa K
    Oncol Rep; 2005 Apr; 13(4):613-20. PubMed ID: 15756432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Signal transducer and activator of transcription-3 inhibitor WP1066 affects human tongue squamous cell carcinoma proliferation and apoptosis in vitro and in vivo].
    Huang Y; Zhou X; Liu A; Li S; Wang X; Zhang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 May; 49(5):308-13. PubMed ID: 25031007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
    Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
    Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
    Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
    Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
    Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.